Stock Details
BHC is Bausch Health Companies Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 29.24$. Average daily volumn in 3 months 2.13M. Market cap 10.50B



Stock symbol : BHC. Exchange : NYSE. Currency : USD
Lastest price : 29.25$. Total volume : 1.44M. Market state PRE
Click reload if you want to check the lastest price on market!!!

Bausch Health Companies Inc. (BHC)
Last Price
29.25$
Change
-0.34
Volume
1.44M

Previous Close29.59
Open29.59
Day Range29.10-29.64
Bid0.00 x 800
Ask0.00 x 900
Volume1.44M
Average Volume2.13M
Market Cap10.5B
Beta1.69
52 Week Range14.86-34.80
Trailing P/EN/A
Foward P/E6.12
Dividend (Yield %)N/A
Ex-Dividend Date2010-11-10



Financial Details


According to Bausch Health Companies Inc.'s financial reports the company's revenue in 2020 were 8.03B an decrease(0%) over the years 2019 revenue that were of 8.6B. In 2020 the company's total earnings were -560M while total earnings in 2019 were -1.79B(-44%).


Loading ...



Organization

Bausch Health Companies Inc. is a multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health and neurology. Bausch Health owns Bausch & Lomb, a supplier of eye health products.

Bausch Health Companies Inc._logo

Market Cap:
10.50B
Revenue:
8.03B
Total Assets:
31.2B
Total Cash:
605M


News about "Bausch Health Companies Inc."

Bausch Health earnings: here's what to expect

Bausch Health will release figures for Q2 on August 3. Analysts on Wall Street expect Bausch Health will release earnings per share of $0.947. Go here to watch Bausch Health stock ...

Source from : Business Insider - 1 days ago


Bausch Health Companies Inc. (NYSE: BHC) Analysis: Is It The One Youโ€™re Looking For?

Bausch Health Companies Inc. (NYSE:BHC) traded at $28.60 at close of the session on Friday, 07/23/21, made an upward move of 0.03% on its previous dayโ€™s price. Looking at the stock we see that its ...

Source from : stocksregister - 7 days ago


Custom Pre-earnings Bullish Diagonal Trigger in Bausch Health Companies Inc

Today we use the new and improved version of a pre-earnings momentum strategy. This goes beyond just naked long a call, and gives the opportunity for two shots at momentum with one trade. This custom ...

Source from : cmlviz.com - 12 days ago


Bausch Health (BHC) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Bausch Health (BHC) reports results for the quarter ended June ...

Source from : Business Insider - 5 days ago


Bausch Health Companies Inc BHC

Bausch Health slightly underperformed our expectations ... rather than any significant issue with margin. We think the company can return to probability in 2022, though this expectation could ...

Source from : Morningstar%2c Inc. - 6 days ago


Bausch Health Companies Inc. Will Release Second-Quarter 2021 Financial Results On August 3

LAVAL, QC, July 6, 2021 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its second-quarter 2021 financial results on Tuesday, Aug. 3, 2021. Bausch Health will ...

Source from : Yahoo Finance - 27 days ago


Bausch Health Cos. Inc.

1 Day BHC -0.78% DJIA -0.31% S&P 500 -0.35% Health Care/Life Sciences 0.22% Joseph C. Papa Chairman & Chief Executive Officer Prometheus Biosciences, Inc, Bausch Health Cos., Inc. Brett M.

Source from : Wall Street Journal - 20 days ago


Global Myopia Progression Market Foraying into Emerging Economies| ALCON Inc., Bausch Health Companies Inc, Johnson & Johnson Vision

The Myopia Progression Market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in million square meters & revenue in USD million from 2021 to ...

Source from : manometcurrent.com - 10 days ago


Cutaneous T-cell Lymphoma Market Clinical Research by Experts 2021| Bausch Health Companies Inc., Celgene Corporation, Helsinn Healthcare SA

The report presents an in-depth assessment of the Cutaneous T-cell Lymphoma Market including enabling technologies, key trends, market drivers, challenges, regulatory landscape, deployment models ...

Source from : openpr.com - 13 days ago


Anticoagulant Reversal Drugs Market โ€“ Size, Trends and Forecast 2027 | Boehringer Ingelheim GmbH, Fresenius Kabi AG, Bausch Health Companies, Inc.

The key players currently engaged in anticoagulant reversal drugs market include Boehringer Ingelheim GmbH, Fresenius Kabi AG, Bausch Health Companies, Inc., CSL Behring Limited, Octapharma AG ...

Source from : Benzinga.com - 19 days ago


Postpartum Depression Market Size, Industry Reportโ€ฆ

The major players covered in the postpartum depression market are GlaxoSmithKline Plc., Alvogen, Bausch Health Companies Inc., Mylan N.V., Novartis AG, Sun Pharmaceutical Industries Ltd., Teva ...

Source from : PharmiWeb - 10 days ago


Allergic Conjunctivitis Drugs Market Analysis, Topโ€ฆ

If diagnosed and treated at early stages, it does not cause any other serious health problems. The common symptoms associated ... Highlights key business priorities to assist companies to realign ...

Source from : PharmiWeb - 7 days ago


Bausch Health Companies Inc. Will Release Second-Quarter 2021 Financial Results On August 3

DISCLAIMER FOR COMMENTS: The views expressed by public comments are not those of this company or its affiliated companies. Please note by clicking on "Post" you acknowledge that you have read the ...

Source from : WFMZ-TV - 27 days ago


Bausch Health Companies Inc BVF

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Source from : Morningstar%2c Inc. - 3 days ago


Bausch Health Cos. Inc.

Joseph C. Papa Chairman & Chief Executive Officer Prometheus Biosciences, Inc, Bausch Health Cos., Inc. Brett M. Icahn Independent Director Icahn Enterprises G.P. Inc., Icahn Enterprises LP ...

Source from : Wall Street Journal - 7 days ago


NYSE:BHC (Bausch Health Companies)

For Canadian companies Bausch Health Companies Inc. (TSX:BHC)(NYSE:BHC) and Bombardier, Inc. (TSX:BBD.B), a name change has made all the difference for investors. More ยป ...

Source from : The Motley Fool Canada - 6 days ago


Bausch Health Companies Inc. Will Release Second-Quarter 2021 Financial Results On August 3

LAVAL, QC, July 6, 2021 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its second-quarter 2021 financial results on Tuesday, Aug. 3, 2021. Bausch Health will host ...

Source from : Yahoo Canada Sports - 27 days ago


Bausch Health Cos. Inc.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Source from : Barron's - 5 days ago


Bausch Health Cos Inc

When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Source from : Bloomberg - 13 days ago


Bausch Health Companies Inc. (BHC.TO)

*Close price adjusted for splits.**Adjusted close price adjusted for both dividends and splits. Loading more data ...

Source from : Yahoo Finance - 10 days ago


Bausch Health Companies Inc (BHC) NPV

The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of ...

Source from : Hargreaves Lansdown - 24 days ago


NYSE:BHC (Bausch Health Companies)

Investors may want to think about trimming their positions in stocks such as Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB), which is down -17% during July. More ยป ...

Source from : The Motley Fool Canada - 6 days ago


Glenmark and Bausch Health join together to commercialize RYALTRIS รขโ€žยข nasal spray in Canada

President of Bausch Health, Canada. In Canada, allergic rhinitis is estimated to afflict 25% of the population, and can have a significant impact on sleep, work and school performancei.

Source from : Webindia 123 - 18 days ago


Bausch Health Announces D. Robert Hale Has Resigned From Its Board Of Directors

(MENAFN - PR Newswire) LAVAL, QC, June 21, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that D. Robert Hale has resigned ...

Source from : Middle East North Africa Financial Network - 1 month ago


Bausch Health To Reduce Debt By $150 Million Using Cash Generated From Operations

LAVAL, Quebec, July 1, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduce debt by $150 million through the ...

Source from : Yahoo - 1 month ago


Bausch Health Announces D. Robert Hale Has Resigned From Its Board Of Directors

LAVAL, QC, June 21, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that D. Robert Hale has resigned from his role as an ...

Source from : WFMZ-TV - 1 month ago


Bausch Health To Reduce Debt By $150 Million Using Cash Generated From Operations

The MarketWatch News Department was not involved in the creation of this content. LAVAL, Quebec, July 1, 2021 /PRNewswire via COMTEX/ -- LAVAL, Quebec, July 1, 2021 /PRNewswire/ -- Bausch Health ...

Source from : MarketWatch - 1 month ago


Bausch Health To Reduce Debt By $150 Million Using Cash Generated From Operations

LAVAL, Quebec, July 1, 2021 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduce debt by $150 million through the redemption of ...

Source from : Yahoo Finance - 1 month ago


Bausch Health reduces debt by $150 million by redeeming bonds

Bausch Health Industries Inc. said Thursday it is reducing its debt by $150 million through the redemption of outstanding bonds using cash from operations. The company, the former Valeant ...

Source from : MSN - 1 month ago


The Chart for Bausch Health Companies Inc. (BHC) Is Flashing Mixed Signals

Bausch Health Companies Inc. (NYSE:BHC) went up by 5.12% from its latest closing price compared to the recent 1-year high of $34.80. The companyโ€™s stock price has collected 1.76% of gains in the last ...

Source from : newsheater - 8 month ago


Bausch Health Companies Inc

Bausch Health Cos Inc, Assertio Therapeutics Inc and Lupin Pharmaceuticals Inc must face claims by purchasers of Bausch's type 2 diabetes drug Glumetza that they conspired to suppress generic ...

Source from : Reuters - 1 year ago


Bausch Health Companies Inc

Bausch Health Cos., Inc. engages in the development ... in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada. PRICE (USD) DAILY ...

Source from : U.S. News & World Report - 1 year ago


Bausch Health Cos. Inc.

Healthcare ยป Drug Manufacturers - Other ยป Bausch Health Cos. Inc. Menu options for Bausch Health Cos. Inc. Data on cases, clients, outside counsel and individual attorneys collected from active ...

Source from : Law360 - 1 year ago


Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Recipients

LAVAL, Quebec, July 29, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care ...

Source from : Yahoo - 4 days ago


Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Recipients

LAVAL, Quebec, July 29, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care ...

Source from : PR Newswire - 3 days ago


Bausch + Lomb has eyes for Waterford_image

Bausch + Lomb has eyes for Waterford

The largest supplier of contact lenses in the world is to expand its base in County Waterford in Ireland where it has operated for more than four decades ...

Source from : Big News Network.com - 12 days ago


Bausch Faces $3 Billion in Claims Left From Valeant Stock Suit

Bausch Health Cos.owes a group of investment funds more than $3 billion for stock losses caused by spurious accounting at its predecessor, Valeant Pharmaceuticals, investors suing the company alleged ...

Source from : Bloomberg Law - 2 days ago


BHC September 10th Options Begin Trading

Investors in Bausch Health Companies Inc (Symbol: BHC) saw new options become available today, for the September 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...

Source from : Nasdaq - 3 days ago


BHC September 3rd Options Begin Trading

Investors in Bausch Health Companies Inc (Symbol: BHC) saw new options become available today, for the September 3rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...

Source from : Nasdaq - 11 days ago


Salix Announces 2021 Gastrointestinal Health Scholars Program Winners

LAVAL, Quebec, July 22, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals ...

Source from : PR Newswire - 10 days ago


Salix Announces 2021 Gastrointestinal Health Scholars Program Winners

Ten Students Affected by Gastrointestinal Disease Will Each Receive a $10,000 Scholarship LAVAL, Quebec, July 22, 2021 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its ...

Source from : Yahoo Finance - 11 days ago


Contact Lenses Market growth in Apparel, Accessories & Luxury Goods Industry | Emerging Trends, Company Risk, and Key Executives | Technavio_image

Contact Lenses Market growth in Apparel, Accessories & Luxury Goods Industry | Emerging Trends, Company Risk, and Key Executives | Technavio

Set to grow by USD 3.92 billion during, Technavio's latest market research report estimates the contact lenses market to register a CAGR of over 5%. With a focus on iden ...

Source from : Troy Record - 10 days ago


BHC Jul 2021 27.500 call

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical companies in the world ...

Source from : Yahoo Finance - 11 days ago